| Product No | EMEA/H/C/000297 |
|---|---|
| Brand Name | Myocet liposomal (previously Myocet) |
| Nonproprietary Name | doxorubicin |
| API | doxorubicin hydrochloride |
| ATC Code | L01DB01 |
| Indications | Myocet liposomal, in combination with cyclophosphamide, is indicated for the first-line treatment of metastatic breast cancer in adult women. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Teva B.V. |
| Status | Authorised(授权) |
| Authorization Date | 2000-07-13 |
| Version | 24 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information